Predicted Trait | |
Reported Trait | Coronary artery disease |
Mapped Trait(s) | coronary artery disease (EFO_0001645) |
Score Construction | |
PGS Name | GRS50 |
Development Method | |
Name | Genome-wide significant variants |
Parameters | Also includes the SNPs from GRS 27 (Mega et al.; PMID:25748612) |
Variants | |
Original Genome Build | NR |
Number of Variants | 50 |
Effect Weight Type | log(OR) |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000004 |
Citation (link to publication) | Tada H et al. Eur Heart J (2015) |
Ancestry Distribution | |
Source of Variant Associations (GWAS) | |
PGS Evaluation |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
Europe PMC: 21966275 |
[
|
European | 10 cohorts
|
Europe PMC: 21966275 |
[
|
South Asian | LOLIPOP, PROMIS |
Europe PMC: 23202125 |
[
|
European, South Asian | 34 cohorts
|
GWAS Catalog: GCST000998 Europe PMC: 2137899 |
86,995 individuals | European | NR |
GWAS Catalog: GCST000999 Europe PMC: 21378988 |
14,790 individuals | South Asian (India, Pakistan) |
NR |
GWAS Catalog: GCST000999 Europe PMC: 21378988 |
15,682 individuals | European | NR |
GWAS Catalog: GCST000338 Europe PMC: 19198612 |
2,520 individuals | European | NR |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM000016 | PSS000010| European Ancestry| 23,595 individuals |
PGP000004 | Tada H et al. Eur Heart J (2015) |
Reported Trait: Incident coronary heart disease | HR: 1.23 [1.18, 1.28] | — | — | age, sex, systolic blood pressure, hypertension treatment, smoking, apoB, apoA-I, prevalent diabetes | — |
PPM000589 | PSS000334| European Ancestry| 39,758 individuals |
PGP000083 | Dikilitas O et al. Am J Hum Genet (2020) |Ext. |
Reported Trait: Incident coronary heart disease | HR: 1.2 [1.15, 1.25] | C-index: 0.698 | — | sex, eMERGE site, first five ancestry-specific principal components | Age-as-time-scale Cox regression |
PPM000595 | PSS000336| Hispanic or Latin American Ancestry| 2,194 individuals |
PGP000083 | Dikilitas O et al. Am J Hum Genet (2020) |Ext. |
Reported Trait: Incident coronary heart disease | HR: 1.13 [0.93, 1.36] | C-index: 0.654 | — | sex, eMERGE site, first five ancestry-specific principal components | Age-as-time-scale Cox regression |
PPM000592 | PSS000332| African Ancestry| 7,070 individuals |
PGP000083 | Dikilitas O et al. Am J Hum Genet (2020) |Ext. |
Reported Trait: Incident coronary heart disease | HR: 1.05 [0.94, 1.17] | C-index: 0.649 | — | sex, eMERGE site, first five ancestry-specific principal components | Age-as-time-scale Cox regression |
PPM000618 | PSS000332| African Ancestry| 7,070 individuals |
PGP000083 | Dikilitas O et al. Am J Hum Genet (2020) |Ext. |
Reported Trait: Incident coronary heart disease | HR: 1.05 [0.94, 1.18] | C-index: 0.704 | — | sex, eMERGE site, diabetes, hypertension, hyperlipidemia, statin use, first 5 ancestry-specific principal components | Age-as-time-scale Cox regression |
PPM000614 | PSS000334| European Ancestry| 39,758 individuals |
PGP000083 | Dikilitas O et al. Am J Hum Genet (2020) |Ext. |
Reported Trait: Incident coronary heart disease | HR: 1.2 [1.15, 1.25] | C-index: 0.736 | — | sex, eMERGE site, diabetes, hypertension, hyperlipidemia, statin use, first 5 ancestry-specific principal components | Age-as-time-scale Cox regression |
PPM000622 | PSS000336| Hispanic or Latin American Ancestry| 2,194 individuals |
PGP000083 | Dikilitas O et al. Am J Hum Genet (2020) |Ext. |
Reported Trait: Incident coronary heart disease | HR: 1.12 [0.93, 1.36] | C-index: 0.708 | — | sex, eMERGE site, diabetes, hypertension, hyperlipidemia, statin use, first 5 ancestry-specific principal components | Age-as-time-scale Cox regression |
PPM000496 | PSS000285| European Ancestry| 22,389 individuals |
PGP000076 | Khera AV et al. N Engl J Med (2016) |Ext. |
Reported Trait: Incident coronary artery disease | — | — | Hazard Ratio (HR; top 20% of score vs bottom 20%): 1.98 [1.76, 2.23] | age, sex, self reported education level | — |
PPM000495 | PSS000286| European Ancestry| 21,222 individuals |
PGP000076 | Khera AV et al. N Engl J Med (2016) |Ext. |
Reported Trait: Incident coronary artery disease | — | — | Hazard Ratio (HR; top 20% of score vs bottom 20%): 1.94 [1.58, 2.39] | age, self reported education level, treatment (vitamin E vs aspirin), 5 genetic principal components | — |
PPM000494 | PSS000283| European Ancestry| 7,814 individuals |
PGP000076 | Khera AV et al. N Engl J Med (2016) |Ext. |
Reported Trait: Incident coronary artery disease | — | — | Hazard Ratio (HR; top 20% of score vs bottom 20%): 1.75 [1.46, 2.1] | age, sex, self reported education level, 5 genetic principal components | — |
PPM000029 | PSS000018| Multi-ancestry (including European)| 482,629 individuals |
PGP000007 | Inouye M et al. J Am Coll Cardiol (2018) |Ext. |
Reported Trait: Incident coronary artery disease | HR: 1.263 [1.247, 1.28] | — | — | sex, genetic PCs (1-10), genotyping array | — |
PPM000497 | PSS000284| European Ancestry| 4,260 individuals |
PGP000076 | Khera AV et al. N Engl J Med (2016) |Ext. |
Reported Trait: Coronary artery calcification | — | — | Agatston score (mean, top 20% of GRS): 46.0 [9.0, 54.0] Agatston score (mean, btttom 25% of GRS): 21.0 [18.0, 25.0] |
— | — |
PPM000604 | PSS000335| Hispanic or Latin American Ancestry| 2,493 individuals |
PGP000083 | Dikilitas O et al. Am J Hum Genet (2020) |Ext. |
Reported Trait: Coronary heart disease (incident and prevalent) | OR: 1.2 [1.06, 1.35] | AUROC: 0.769 | — | age at first EHR record, duration of EHR, sex, eMERGE site, first five ancestry-specific principal components | — |
PPM000601 | PSS000331| African Ancestry| 7,597 individuals |
PGP000083 | Dikilitas O et al. Am J Hum Genet (2020) |Ext. |
Reported Trait: Coronary heart disease (incident and prevalent) | OR: 1.05 [0.98, 1.14] | AUROC: 0.763 | — | age at first EHR record, duration of EHR, sex, eMERGE site, first five ancestry-specific principal components | — |
PPM000598 | PSS000333| European Ancestry| 45,645 individuals |
PGP000083 | Dikilitas O et al. Am J Hum Genet (2020) |Ext. |
Reported Trait: Coronary heart disease (incident and prevalent) | OR: 1.28 [1.25, 1.32] | AUROC: 0.75 | — | age at first EHR record, duration of EHR, sex, eMERGE site, first five ancestry-specific principal components | — |
PPM021303 | PSS011680| European Ancestry| 26,203 individuals |
PGP000627 | Martikainen P et al. J Epidemiol Community Health (2021) |Ext. |
Reported Trait: Incident coronary heart disease hospitalization or death | — | — | Hazard Ratio (HR, top 25% vs bottom 25%): 1.55 [1.38, 1.76] | Age as timescale, sex, region of residence, calendar year, study batch, PCs(1-10) | — |
PPM021304 | PSS011680| European Ancestry| 26,203 individuals |
PGP000627 | Martikainen P et al. J Epidemiol Community Health (2021) |Ext. |
Reported Trait: Incident coronary heart disease hospitalization or death | — | — | Hazard Ratio (HR, top 25% vs bottom 25%): 1.56 [1.38, 1.77] | Age as timescale, sex, region of residence, calendar year, study batch, PCs(1-10), education | — |
PPM021305 | PSS011680| European Ancestry| 26,203 individuals |
PGP000627 | Martikainen P et al. J Epidemiol Community Health (2021) |Ext. |
Reported Trait: Incident coronary heart disease hospitalization or death | — | — | Hazard Ratio (HR, top 25% vs bottom 25%): 1.53 [1.35, 1.73] | Age as timescale, sex, region of residence, calendar year, study batch, PCs(1-10), smoking, alcohol use, body mass index, high-density lipoprotein and total cholesterol, blood pressure, diabetes | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS000283 | Composite endpoint of either: myocardial infarction, coronary revascularization, death from coronary causes. | Mean = 18.8 years | [ ,
45.0 % Male samples |
Mean = 54.0 years Sd = 5.7 years |
European | — | ARIC | — |
PSS000284 | Cross-sectional analysis of baseline scores for coronary artery calcification (Agatston score) | — | 4,260 individuals, 44.0 % Male samples |
Mean = 69.1 years Sd = 6.0 years |
European | — | BioImage | — |
PSS000285 | Composite endpoint of either: myocardial infarction, coronary revascularization, death from coronary causes. | Mean = 19.4 years | [ ,
38.0 % Male samples |
Mean = 58.0 years Sd = 7.7 years |
European | — | MDC-CC | — |
PSS000286 | Composite endpoint of either: myocardial infarction, coronary revascularization, death from coronary causes. | Mean = 20.5 years | [ ,
0.0 % Male samples |
Mean = 54.2 years Sd = 7.1 years |
European | — | WGHS | — |
PSS000010 | Incident CHD was defined as coronary revascularization, fatal or nonfatal myocardial infarction, or death due to ischemic heart disease. | — | [ ,
38.03 % Male samples |
— | European (Swedish) |
— | MDC | Prospective study |
PSS000018 | CAD was defined as fatal or nonfatal myocardial infarction (MI) cases, percutaneous transluminal coronary angioplasty (PTCA), or coronary artery bypass grafting (CABG). Prevalent versus incident status was relative to the UKB enrollment assessment. In UKB self-reported data, cases were defined as having had a heart attack diagnosed by a doctor (data field #6150); “non-cancer illnesses that self-reported as heart attack” (data field #20002); or self-reported operation including PTCA, CABG, or triple heart bypass (data field #20004). In HES hospital episodes data and death registry data, MI was defined as hospital admission or cause of death due to ICD-9 410 to 412, or ICD-10 I21 to I24 or I25.2; CABG and PTCA were defined as hospital admission OPCS-4 K40 to K46, K49, K50.1,or K75. | — | [ ,
45.6 % Male samples |
— | European, NR | ~95% European ancestry samples, <5% non-European ancestry | UKB | — |
PSS011680 | At baseline, all individuals were free from coronary heart disease (CHD). Cases included individuals who were hospitalised due to CHD or suffered a fatal CHD event. CHD events were defined for non-fatal cases as the International Classification of Diseases ninth revision (ICD-9) codes 410 and 4110 (years 1992-1995) and ICD-10 codes I200, I21 or I22 (1996-2015) and Nordic Medico-Statistical Committee codes for coronary artery bypass graft or percutaneous coronary intervention in the hospital discharge register, and for fatal cases as ICD-9 codes 410-414 and 798 (not 7980A) and ICD-10 codes I20-25, I46, R96 and R98 in the causes of death register. | Mean = 13.8 years | [ ,
46.74 % Male samples |
Mean = 48.0 years | European (Finnish) |
— | FINRISK | — |
PSS000331 | CHD was defined as occurrence of either myocardial infarction (MI) or coronary revascularization events (such as percutaneous coronary intervention or coronary artery bypass grafting) using ICD codes. Individuals with MI were defined as those whose EHR included at least two related diagnostic codes on separate occasions within a 5-day window, and individuals with coronary revascularization were defined as those who had at least one relevant procedural code in the EHR. ICD codelists and phenotyping algorithm in PMID:27678441 and PMID:25717410 | Median = 9.2 years IQR = [5.5, 13.0] years |
[ ,
31.0 % Male samples |
Mean = 43.6 years Sd = 12.5 years |
African American or Afro-Caribbean | — | 7 cohorts
|
right censored at age 75 years or at the age of last observation (whichever was first) |
PSS000332 | CHD was defined as occurrence of either myocardial infarction (MI) or coronary revascularization events (such as percutaneous coronary intervention or coronary artery bypass grafting) using ICD codes. Individuals with MI were defined as those whose EHR included at least two related diagnostic codes on separate occasions within a 5-day window, and individuals with coronary revascularization were defined as those who had at least one relevant procedural code in the EHR. We identified the first CHD event and classified it as ‘‘incident’’ if the event occurred at least 6 months after the participant’s first record in the EHR and if there were no previous ICD-9-CM or ICD-10-CM codes associated with CHD. ICD codelists and phenotyping algorithm in PMID:27678441 and PMID:25717410 | Median = 9.2 years IQR = [5.5, 13.0] years |
[ ,
31.0 % Male samples |
Mean = 43.6 years Sd = 12.5 years |
African American or Afro-Caribbean | — | 7 cohorts
|
right censored at age 75 years or at the age of last observation (whichever was first) |
PSS000333 | CHD was defined as occurrence of either myocardial infarction (MI) or coronary revascularization events (such as percutaneous coronary intervention or coronary artery bypass grafting) using ICD codes. Individuals with MI were defined as those whose EHR included at least two related diagnostic codes on separate occasions within a 5-day window, and individuals with coronary revascularization were defined as those who had at least one relevant procedural code in the EHR. ICD codelists and phenotyping algorithm in PMID:27678441 and PMID:25717410 | Median = 11.7 years IQR = [6.0, 18.5] years |
[ ,
44.6 % Male samples |
Mean = 49.0 years Sd = 14.1 years |
European | — | 11 cohorts
|
right censored at age 75 years or at the age of last observation (whichever was first) |
PSS000334 | CHD was defined as occurrence of either myocardial infarction (MI) or coronary revascularization events (such as percutaneous coronary intervention or coronary artery bypass grafting) using ICD codes. Individuals with MI were defined as those whose EHR included at least two related diagnostic codes on separate occasions within a 5-day window, and individuals with coronary revascularization were defined as those who had at least one relevant procedural code in the EHR. We identified the first CHD event and classified it as ‘‘incident’’ if the event occurred at least 6 months after the participant’s first record in the EHR and if there were no previous ICD-9-CM or ICD-10-CM codes associated with CHD. ICD codelists and phenotyping algorithm in PMID:27678441 and PMID:25717410 | Median = 11.7 years IQR = [6.0, 18.5] years |
[ ,
44.6 % Male samples |
Mean = 49.0 years Sd = 14.1 years |
European | — | 11 cohorts
|
right censored at age 75 years or at the age of last observation (whichever was first) |
PSS000335 | CHD was defined as occurrence of either myocardial infarction (MI) or coronary revascularization events (such as percutaneous coronary intervention or coronary artery bypass grafting) using ICD codes. Individuals with MI were defined as those whose EHR included at least two related diagnostic codes on separate occasions within a 5-day window, and individuals with coronary revascularization were defined as those who had at least one relevant procedural code in the EHR. ICD codelists and phenotyping algorithm in PMID:27678441 and PMID:25717410 | Median = 10.4 years IQR = [5.7, 14.7] years |
[ ,
36.2 % Male samples |
Mean = 41.1 years Sd = 13.2 years |
Hispanic or Latin American | — | 8 cohorts
|
right censored at age 75 years or at the age of last observation (whichever was first) |
PSS000336 | CHD was defined as occurrence of either myocardial infarction (MI) or coronary revascularization events (such as percutaneous coronary intervention or coronary artery bypass grafting) using ICD codes. Individuals with MI were defined as those whose EHR included at least two related diagnostic codes on separate occasions within a 5-day window, and individuals with coronary revascularization were defined as those who had at least one relevant procedural code in the EHR. We identified the first CHD event and classified it as ‘‘incident’’ if the event occurred at least 6 months after the participant’s first record in the EHR and if there were no previous ICD-9-CM or ICD-10-CM codes associated with CHD. ICD codelists and phenotyping algorithm in PMID:27678441 and PMID:25717410 | Median = 10.4 years IQR = [5.7, 14.7] years |
[ ,
36.2 % Male samples |
Mean = 41.1 years Sd = 13.2 years |
Hispanic or Latin American | — | 8 cohorts
|
right censored at age 75 years or at the age of last observation (whichever was first) |